Deferasirox D4
| Product Name | Deferasirox D4 |
|---|---|
| Alternate Names | Deferasirox Stable Isotopes, Stable Isotopes of Deferasirox |
| CAT No. | CS-O-02863 |
| CAS No. | 1133425-75-8 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 377.39 g/mol |
| Mol. For. | C₂₁H₁₁D₄N₃O₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Deferasirox |
| Purity | Not less than 95 % |
| Smileys | OC(C=CC=C1)=C1C2=NC(C(C=CC=C3)=C3O)=NN2C(C([2H])=C4[2H])=C(C([2H])=C4C(O)=O)[2H] |
| Canonical Smiles | C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O |
| InchIKey | BOFQWVMAQOTZIW-IRYCTXJYSA-N |
| Inchl | InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28)/i9D,10D,11D,12D |
| IUPAC | 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]-2,3,5,6-tetradeuteriobenzoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Deferasirox D4 is a deuterated version of the iron-chelating drug, Deferasirox. It is used for the treatment of chronic iron overload caused by blood transfusions in patients with thalassemia or other anemias.
The chemical formula of Deferasirox D4 is C21H26D4N3O5. It is a white to yellowish powder that is slightly soluble in water. Deferasirox D4 is a selective and orally active iron chelator that works by binding to excess iron in the body and promoting its excretion through urine and feces.
Deferasirox D4 is available in tablet form for oral administration. The recommended dosage is based on the patient's body weight and the amount of iron overload. The tablets should be taken once daily with water on an empty stomach, at least 30 minutes before food.
Deferasirox D4 has been shown to be effective in reducing iron overload in patients with thalassemia or other anemias. However, it may cause some side effects such as nausea, vomiting, diarrhea, abdominal pain, and skin rash. In rare cases, it may also cause kidney or liver problems.
In conclusion, Deferasirox D4 is a useful medication for the treatment of iron overload caused by blood transfusions. It works by binding to excess iron in the body and promoting its excretion. However, it may cause some side effects and should only be used under the supervision of a healthcare professional.
Get an Instant Quote
Related Compounds
Deferasirox 13C6 | Deferasirox D8 | Deferasirox-d4 (major) (Mixture of 6-hydroxyphenyl-d4 isomers) |